Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic Cancer

Figure 6

Association between the risk model and patients’ survival and clinicopathological characteristics in pancreatic cancer (PC). (a, b) Kaplan-Meier (KM) analysis of TCGA pancreatic cancer patients was stratified by median risk. (a) Overall survival (OS) was significantly higher in the low-risk group than in the high-risk group. (b) Disease-free survival (DFS) was significantly higher in the low-risk group than in the high-risk group. (c) KM analysis of OS in the GSE57495 dataset. (d) KM analysis of OS in the GSE79668 dataset. (e) Patients with advanced stage ( value = 4.592-06), higher histologic grade ( value = 0.002), or diabetes history ( value = 0.043) had higher risk scores.

(a)

(b)

(c)

(d)

(e)